ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)

September 27, 1991

IOM Report Links Agent Orange, CLL

January 24, 2003

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013